NEWS

Costa Rica's Next Medtech Move

Costa Rica has already proven it can play the MedTech game. As a prime hub to global leaders, the country meets the world's most demanding regulatory standards and has grown medical devices into its largest export sector, reaching US$10.8 billion in 2025. So, what comes next?

In its latest feature, Costa Rica’s medtech bet: from making devices to engineering them, The European explores how Costa Rica is moving beyond manufacturing to become a destination for high-value engineering, research and development, and innovation in the life sciences sector.

"The shift toward more sophisticated and complex functions reflects the maturity of Costa Rica’s ecosystem. We are no longer just a place where medical devices are made. We are at the forefront of innovation, shaping what comes next for the industry," says Marianela Urgellés, Managing Director at CINDE.

The coming years will be focused on closing strategic gaps across the ecosystem, particularly at the intersection of digital technologies, electronics, and MedTech. That's why CINDE's team will be taking the country's case to Electronica and MEDICA, where they'll target the next wave of investment in these key capabilities.

Connect with our Investment Advisory Team to learn how your company can grow and succeed alongside Costa Rica.

About CINDE

CINDE is the expert and strategic guide for investment, business development, and talent initiatives in Costa Rica. Drawing on 44 years of work with multinational companies and its role as a key player in the investment ecosystem, CINDE has developed dozens of talent-development initiatives as a core element of Costa Rica's business climate and has supported the establishment of more than 450 multinational companies.